6 KRW
−3.88 B KRW
234.90 B KRW
86.95 M
About YUNGJIN PHARM
Sector
CEO
Gi-Soo Lee
Headquarters
Seoul
Website
Founded
1962
ISIN
KR7003520004
FIGI
BBG000BDQSK6
Yungjin Pharm. Co., Ltd. engages in the development, production, and distribution of pharmaceuticals. Its products include cephalosporin, antibiotics, drugs for the central nervous system, cardiovascular, endocrine system, urinary system, respiratory, anti-inflammatory and analgesics, anti-histamine, anti-fungal, total nutrition, vitamin and supplement, cosmetics, and tonic drinks. The company was founded on July 16, 1962 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 003520 is 1,988 KRW — it has decreased by −0.61% in the past 24 hours. Watch YUNGJIN PHARM stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange YUNGJIN PHARM stocks are traded under the ticker 003520.
003520 stock has fallen by −2.16% compared to the previous week, the month change is a −9.53% fall, over the last year YUNGJIN PHARM has showed a −5.33% decrease.
003520 reached its all-time high on May 24, 2016 with the price of 19,200 KRW, and its all-time low was 488 KRW and was reached on Oct 28, 2008. View more price dynamics on 003520 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
003520 stock is 3.50% volatile and has beta coefficient of 0.70. Track YUNGJIN PHARM stock price on the chart and check out the list of the most volatile stocks — is YUNGJIN PHARM there?
Today YUNGJIN PHARM has the market capitalization of 355.73 B, it has decreased by −2.66% over the last week.
Yes, you can track YUNGJIN PHARM financials in yearly and quarterly reports right on TradingView.
003520 net income for the last quarter is −436.54 M KRW, while the quarter before that showed −1.46 B KRW of net income which accounts for 70.02% change. Track more YUNGJIN PHARM financial stats to get the full picture.
No, 003520 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 624.00 employees. See our rating of the largest employees — is YUNGJIN PHARM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. YUNGJIN PHARM EBITDA is 18.41 B KRW, and current EBITDA margin is 5.03%. See more stats in YUNGJIN PHARM financial statements.
Like other stocks, 003520 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade YUNGJIN PHARM stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So YUNGJIN PHARM technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating YUNGJIN PHARM stock shows the sell signal. See more of YUNGJIN PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.